Predictive medicine provides increasingly precise and more accessible ways to determine individual risks to develop a condition in the future. Symptom-based diagnostics of diseases and their therapy are thus increasingly being supplemented or even replaced by new methods of prediction and prevention. However, these improvements for medical care are also accompanied by a wide range of impacts on the life of the individual, on the health care system and on our society.
For Alzheimer's disease (AD), early detection capabilities are also rapidly evolving. Likely, there will very soon be basic blood tests allowing prediction of an individual's risk for AD, which will be accessible to a broad population. These and other examples suggest that prediction will become increasingly essential to health care. Its impact on people's perceptions of health and disease, its actual use, and its specific effects in a solidarity-based health care system are, however, largely unclear.
This development raises a number of questions:
The PreTAD project will therefore initially identify individual needs and different perspectives of people regarding the prediction of AD. For this purpose, individuals with first symptoms (SCD, subjective cognitive decline), individuals with family history of AD or APOE4 allele carriers as well as healthy individuals will be questioned in this study.
Moreover, an overall goal of the project is to identify the effects of the paradigm shift in medicine from an individual, linguistic, legal and societal perspective in order to derive implications for practice. On this basis, recommendations for the practical handling of the possibilities of predictive medicine will be developed for the prediction and medical care of AD.
ceres – Cologne Center for Ethics, Rights, Economics, and Social Sciences of Health
+49 (0)221 - 470 89115